Leonite Fund I, LP - 18 Feb 2025 SCHEDULE 13G Report for ReShape Lifesciences Inc. Common Shares, $0.001 par value per share (RSLS)

Filing Manager: Leonite Fund I, LP
Reporting Manager: Leonite Fund I, LP
Security: ReShape Lifesciences Inc. Common Shares, $0.001 par value per share
Symbol: RSLS
Shares outstanding: 3,278,689 shares
Disclosed Ownership: 200,000 shares
Ownership: 6.1%
Form type: SCHEDULE 13G
Filing time: 24 Feb 2025, 15:02:52 UTC
Date of event: 18 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Leonite Fund I, LP	6.1%	200,000	200,000	0	Avi Geller	Avi Geller, chief investment officer
Geller Avi	6.1%	200,000	200,000	0	Avi Geller	Avi Geller, an individual